AMR Patient Group
The first European AMR Patient Group was officially launched on the 18th November 2020 to coincide with European Antibiotic Awareness Day 2020 and World Antimicrobial Awareness Week (18-24 November). The AMR Patient Group is an initiative by Health First Europe and is comprised of national patient associations from across Europe. The group aims to address the gap in awareness at the patient-level about the danger of antibiotic misuse and the lack of effective infection prevention measures. The AMR Patient Group will empower patients across Europe with the necessary knowledge about antimicrobial resistance so that everyone understands when it is appropriate to take antibiotics and how to take them responsibly.
The key objectives of the AMR Patient Group are:
- Raising patient awareness about AMR and HAIs to help reduce antibiotic misuse.
- Building a consistent patient voice across Europe to advocate for national policies to tackle AMR and HAIs.
- Broadening the AMR debate to include infection prevention and control measures.
What is AMR and why is it important?
Antimicrobial Resistance (AMR) is the ability of a microorganism (e.g., a bacterium, a virus, or a parasite) to resist the action of one or more antimicrobial agents or antibiotics. Levels of antibiotic consumption consistently correlate with levels of antibiotic resistance, i.e. the more an antibiotic is used, the more resistant the bacteria can become. As a result, antibiotics will not be able to treat infections any longer.
Antimicrobial resistance is one of the most serious threats to public health globally. It is responsible for an estimated 33,000 deaths per year in the EU and is estimated to cost the EU €1.5 billion annually in healthcare costs and productivity losses. Without effective antibiotics to prevent or treat infections, some routine surgical operations and cancer chemotherapies may become very high-risk procedures, or even become impossible due to the increased likelihood of resistant infections. Resistant bacteria can kill and can spread to others, creating huge risks for patients and problems for society at large.
Keeping antibiotics effective is everyone’s responsibility. Responsible use of antibiotics can help stop resistant bacteria from developing and help keep antibiotics effective for the use of future generations. On this basis, it is important for everyone to know when it is appropriate to take antibiotics and how to take them responsibly.
View the AMR Patient Group launch press release
AMR Patient Group members
Our members to date include:
Learn more about AMR and other healthcare associated infections (HAI)
To learn more about the work Health First Europe is doing, you can view our dedicated AMR page here.
- EU Action on Antimicrobial Resistance
- EU AMR Action Plan Progress: Making the EU a best practice region – Year 2019
European Centre for Disease Prevention and Control (ECDC)
- Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance – November 2020
- Antimicrobial resistance and consumption remains high in the EU/EEA and the UK, according to new ECDC data – November 2020
- Directory of online resources for the prevention and control of antimicrobial resistance (AMR) and healthcare-associated infections (HAI)
- List of publications on antimicrobial resistance
- Communication toolkit to promote prudent antibiotic use aimed at general public
- Survey of healthcare workers’ knowledge, attitudes and behaviours on antibiotics, antibiotic use and antibiotic resistance in the EU/EEA – November 2019
- Report on a European One Health Action Plan against Antimicrobial Resistance (AMR) (2017/2254(INI)) – July 2018
World Health Organization (WHO)
- Global action plan on antimicrobial resistance – 2015
- Infection prevention and control – Focus on AMR – Tools and resources
Council of the European Union
- Council conclusions on the next steps under a One Health approach to combat antimicrobial resistance – June 2016